Advanced Medical Optics (AMO) has entered into a US patent license agreement with Carl Zeiss Meditec.
Advanced Medical Optics (AMO) has entered into a US patent license agreement with Carl Zeiss Meditec.
AMO's IntraLase subsidiary had granted a non-exclusive, royalty-bearing license to Carl Zeiss Meditec to use the IntraLase patent portfolio to provide femtosecond technology for corneal surgery. No other terms of the agreement have been made public.
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.